首页> 中文期刊> 《海南医科大学学报(英文版)》 >Effect of low-rTMS in combined with edaravone on the inflammatory cytokines and cerebral metabolites in patients with cerebral infarction and aphasia

Effect of low-rTMS in combined with edaravone on the inflammatory cytokines and cerebral metabolites in patients with cerebral infarction and aphasia

         

摘要

Objective:To explore the effect of low-repetitive transcranial magnetic stimulation (low-rTMS) in combined with edaravone on the inflammatory cytokines and cerebral metabolites in patients with cerebral infarction and aphasia.Methods:A total of 70 patients with acute cerebral infarction (ACI) and motor aphasia who were admitted in our hospital from March, 2015 to March, 2016 were included in the study and randomized into the observation group and the control group, 35 in each group. The patients in the control group were given blood pressure reduction, intracranial pressure reduction, blood lipid regulation, anti-platelet aggregation, symptomatic and supportive treatments, edaravone (30 mg) + normal saline (100 mL), ivdrip, 2 times/d, continuously for 2 weeks. On this basis, the patients in the observation group were given additional rTMS, continuously for 10 d. Hs-CRP, IL-6, IL-8, and TNF-α levels before treatment, 1 week and 2 weeks after treatment in the two groups were detected. MRS was used to detect NAA and Cho in Broca district before treatment, 1 week and 2 weeks after treatment in the two groups. ABC was used to evaluate the linguistic function before treatment, 2 weeks, 3 months, and 6 months in the two groups.Results:Hs-CRP, IL-6, IL-8, and TNF-α levels 1 week and 2 weeks after treatment in the observation group were significantly lower than those in the control group (P<0.05). NAA value on the left side 1 week and 2 weeks after treatment in the observation group was significantly higher than that in the control group (P<0.05), while Cho value was significantly lower than that in the control group (P<0.05). ABC score 2 weeks, 3 months, and 6 months after treatment in the observation group was significantly higher than that in the control group (P<0.05).Conclusions:Edaravone in combined with low-rTMS in the treatment of ACI can effectively inhibit the inflammatory reaction, improve the neurological deficit degree, and promote the recovery of cortex language neural network.

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第5期|132-135|共4页
  • 作者单位

    The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China;

    The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China;

    The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China;

    The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China;

    The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China;

    The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号